Nectar Lifesciences has informed that this is in continuation of disclosure by the Company vide letter no. NLL/CS/2026- 730 dated September 18, 2026. In this regard pursuant to regulation 30 of Securities and Exchange of Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015, (LODR Regulations) it has enclosed revised proceedings of AGM held on Friday, September 18, 2026.
The above information is a part of company’s filings submitted to BSE.